208 related articles for article (PubMed ID: 9401367)
1. Cystic fibrosis respiratory infections: interactions between bacteria and host defence.
Döring G
Monaldi Arch Chest Dis; 1997 Aug; 52(4):363-6. PubMed ID: 9401367
[TBL] [Abstract][Full Text] [Related]
2. Interaction between Pseudomonas aeruginosa and host defenses in cystic fibrosis.
Marshall BC; Carroll KC
Semin Respir Infect; 1991 Mar; 6(1):11-8. PubMed ID: 1909452
[TBL] [Abstract][Full Text] [Related]
3. Pseudomonas aeruginosa infection in cystic fibrosis. Relationship between mucoid strains of Pseudomonas aeruginosa and the humoral immune response.
Hoiby N
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):551-8. PubMed ID: 4213330
[No Abstract] [Full Text] [Related]
4. Toll-like receptors in the host defense against Pseudomonas aeruginosa respiratory infection and cystic fibrosis.
McIsaac SM; Stadnyk AW; Lin TJ
J Leukoc Biol; 2012 Nov; 92(5):977-85. PubMed ID: 22892106
[TBL] [Abstract][Full Text] [Related]
5. [Infections of the respiratory tract with Pseudomonas aeruginosa in cystic fibrosis].
Winkler U; Wingender J; Jäger KE
Klin Wochenschr; 1985 Jun; 63(11):490-8. PubMed ID: 3925219
[TBL] [Abstract][Full Text] [Related]
6. Rationale for development of immunotherapies that target mucoid Pseudomonas aeruginosa infection in cystic fibrosis patients.
Pier GB
Behring Inst Mitt; 1997 Feb; (98):350-60. PubMed ID: 9382760
[TBL] [Abstract][Full Text] [Related]
7. Pseudomonas respiratory infection in cystic fibrosis: a possible defect in opsonic IgG antibody?
Fick RB; Reynolds HY
Bull Eur Physiopathol Respir; 1983; 19(2):151-61. PubMed ID: 6871494
[TBL] [Abstract][Full Text] [Related]
8. Pseudomonas aeruginosa infection in cystic fibrosis. Distribution of B and T lymphocytes in relation to the humoral immune response.
Hoiby N; Mathiesen L
Acta Pathol Microbiol Scand B Microbiol Immunol; 1974 Aug; 82(4):559-66. PubMed ID: 4213329
[No Abstract] [Full Text] [Related]
9. Mucoid Pseudomonas aeruginosa growing in a biofilm in vitro are killed by opsonic antibodies to the mucoid exopolysaccharide capsule but not by antibodies produced during chronic lung infection in cystic fibrosis patients.
Meluleni GJ; Grout M; Evans DJ; Pier GB
J Immunol; 1995 Aug; 155(4):2029-38. PubMed ID: 7636254
[TBL] [Abstract][Full Text] [Related]
10. Correlation of serum opsonic activity in cystic fibrosis with colonization and disease state: measurement of opsonins to Pseudomonas aeruginosa by neutrophil superoxide anion generation.
Bender JG; Florman AL; Van Epps DE
Pediatr Res; 1987 Oct; 22(4):383-8. PubMed ID: 2825106
[TBL] [Abstract][Full Text] [Related]
11. Host response to Pseudomonas aeruginosa.
Döring G
Acta Paediatr Scand Suppl; 1989; 363():37-9; discussion 40. PubMed ID: 2518396
[TBL] [Abstract][Full Text] [Related]
12. NET formation induced by Pseudomonas aeruginosa cystic fibrosis isolates measured as release of myeloperoxidase-DNA and neutrophil elastase-DNA complexes.
Yoo DG; Floyd M; Winn M; Moskowitz SM; Rada B
Immunol Lett; 2014 Aug; 160(2):186-94. PubMed ID: 24670966
[TBL] [Abstract][Full Text] [Related]
13. Emergence and persistence of Pseudomonas aeruginosa in the cystic fibrosis airway.
Fick RB; Sonoda F; Hornick DB
Semin Respir Infect; 1992 Sep; 7(3):168-78. PubMed ID: 1475541
[TBL] [Abstract][Full Text] [Related]
14. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
Ciofu O
APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
[TBL] [Abstract][Full Text] [Related]
15. Lung infection with alginate-producing, mucoid Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS
APMIS Suppl; 1992; 28():1-79. PubMed ID: 1449848
[TBL] [Abstract][Full Text] [Related]
16. Infections with Pseudomonas aeruginosa in patients with cystic fibrosis.
Tümmler B; Bosshammer J; Breitenstein S; Brockhausen I; Gudowius P; Herrmann C; Herrmann S; Heuer T; Kubesch P; Mekus F; Römling U; Schmidt KD; Spangenberg C; Walter S
Behring Inst Mitt; 1997 Feb; (98):249-55. PubMed ID: 9382747
[TBL] [Abstract][Full Text] [Related]
17. Association with phagocytic inhibition of anti-Pseudomonas aeruginosa immunoglobulin G antibody subclass levels in serum from patients with cystic fibrosis.
Shryock TR; Mollé JS; Klinger JD; Thomassen MJ
J Clin Microbiol; 1986 Mar; 23(3):513-6. PubMed ID: 3082922
[TBL] [Abstract][Full Text] [Related]
18. Pseudomonas aeruginosa infection in cystic fibrosis. Occurrence of precipitating antibodies against pseudomonas aeruginosa in relation to the concentration of sixteen serum proteins and the clinical and radiographical status of the lungs.
Hoiby N; Jacobsen L; Jorgensen BA; Lykkegaard E; Weeke B
Acta Paediatr Scand; 1974 Nov; 63(6):843-8. PubMed ID: 4215280
[No Abstract] [Full Text] [Related]
19. Immuno-modulatory functions of the type-3 secretion system and impacts on the pulmonary host defense: A role for ExoS of Pseudomonas aeruginosa in cystic fibrosis.
Belmadi N; Wu Y; Touqui L
Toxicon; 2018 Mar; 143():68-73. PubMed ID: 29339019
[TBL] [Abstract][Full Text] [Related]
20. Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.
Li Z; Kosorok MR; Farrell PM; Laxova A; West SE; Green CG; Collins J; Rock MJ; Splaingard ML
JAMA; 2005 Feb; 293(5):581-8. PubMed ID: 15687313
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
